Evidence Library
Filter by drug, type, year, and open access.
Showing 1–4 of 4 results
- Assessing the metabolic impact of aripiprazole versus risperidone in the treatment of schizophrenia: a randomized double-blind controlled clinical trial — BMC Psychiatry (2025)• Drug: risperidoneOpen accessPMID
- Pharmacological treatments for antipsychotic-induced hyperprolactinemia: network meta-analysis. — Translational Psychiatry (2022)• Drug: risperidoneOpen accessDOIPMIDPMCID
- Risperidone and prolactin: safety review — Review (2019)• Drug: risperidone
- Risperidone efficacy in schizophrenia: meta‑analysis — Meta‑analysis (2018)• Drug: risperidone